No abstract

No abstract

Objective-Vascular endothelial growth factor (VEGF) exerts proangiogenic action and induces activation of a variety of proangiogenic signaling pathways, including the Rho family small G proteins. However, regulators of the Rho family small G proteins in vascular endothelial cells (ECs) are poorly understood. Here we attempted to clarify the expression, subcellular localization, downstream effectors, and proangiogenic role of FGD5, a member of the FGD family of guanine nucleotide exchange factors. Methods and Results-FGD5 was shown to be selectively expressed in cultured human vascular ECs. Immunofluorescence microscopy showed that the signal for FGD5 was observed at peripheral membrane ruffles and perinuclear regions in human umbilical vein ECs. Overexpression of FGD5 increased Cdc42 activity, whereas knockdown of FGD5 by small interfering RNAs inhibited the VEGF-induced activation of Cdc42 and extracellular signal-regulated kinase. VEGF-promoted capillary-like network formation, permeability, directional movement, and proliferation of human umbilical vein ECs and the reorientation of the Golgi complex during directional cell movement were attenuated by knockdown of FGD5. Conclusion-This

Cyclical activation and inactivation of Rho family small G proteins, such as Rho, Rac, and Cdc42, are needed for moving cells to form leading edge structures in response to chemoattractants. However, the mechanisms underlying the dynamic regulation of their activities are not fully understood. We recently showed that another small G protein, Rap1, plays a crucial role in the platelet-derived growth factor (PDGF)-induced formation of leading edge structures and activation of Rac1 in NIH3T3 cells. We showed here that knockdown of afadin, an actin-binding protein, in NIH3T3 cells resulted in a failure to develop leading edge structures in association with an impairment of the activation of Rap1 and Rac1 and inactivation of RhoA in response to PDGF. Overexpression of a constitutively active mutant of Rap1 (Rap1-CA) and knockdown of SPA-1, a Rap1 GTPase-activating protein that was negatively regulated by afadin by virtue of binding to it, in afadin-knockdown NIH3T3 cells restored the formation of leading edge structures and the reduction of the PDGF-induced activation of Rac1 and inactivation of RhoA, suggesting that the inactivation of Rap1 by SPA-1 is responsible for inhibition of the formation of leading edge structures. The effect of Rap1-CA on the restoration of the formation of leading edge structures and RhoA inactivation was diminished by additional knockdown of ARAP1, a Rap-activated Rho GAP, which localized at the leading edges of moving NIH3T3 cells. These results indicate that afadin regulates the cyclical activation and inactivation of Rap1, Rac1, and RhoA through SPA-1 and ARAP1.

for the recruitment of afadin and the tyrosine phosphatase SHP-2 to the leading edge. SHP-2 was previously reported to tightly regulate the activation of PDGF receptor and its downstream signaling pathway for the formation of the leading edge. These results indicate that afadin has a novel role in PDGF-induced directional cell movement, presumably in cooperation with active Rap1 and SHP-2.Supplementary material available online at

Rationale: Vascular endothelial growth factor (VEGF), a major proangiogenic agent, exerts its proangiogenic action by binding to VEGF receptor 2 (VEGFR2), the activity of which is regulated by direct interactions with other cell surface proteins, including integrin ␣ V ␤ 3 . However, how the interaction between VEGFR2 and integrin ␣ V ␤ 3 is regulated is not clear. Objective:To investigate whether Necl-5/poliovirus receptor, an immunoglobulin-like molecule that is known to bind integrin ␣ V ␤ 3 , regulates the interaction between VEGFR2 and integrin ␣ V ␤ 3 , and to clarify the role of Necl-5 in the VEGF-induced angiogenesis. Key Words: cell adhesion molecules Ⅲ angiogenesis Ⅲ peripheral vascular disease A ngiogenesis plays an important role in diverse developmental, physiological, and pathological processes. Angiogenesis is triggered by the interaction of proangiogenic growth factors and extracellular matrix with their receptors. Vascular endothelial growth factor (VEGF) is a major proangiogenic agent that regulates multiple key steps of angiogenesis. VEGF exerts its proangiogenic action by binding to VEGF receptor 2 (VEGFR2). The activity of VEGFR2 is regulated by direct interactions with other cell surface proteins, such as coreceptor neuropilins 1 and adhesion molecules, including VE-cadherin 2 and integrins. 3 Integrins, including integrin ␣ V ␤ 3 , are critically involved in angiogenesis and initiate signals that control cell migration, proliferation, and survival. 4 Receptors such as VEGFR2 and plateletderived growth factor (PDGF) receptor (PDGFR) interact with integrins, and these interactions exhibit synergistic effects and cooperatively regulate diverse intracellular signals that control key cell functions. 3,5,6 However, how the interaction between VEGFR2 and integrin ␣ V ␤ 3 through their extracellular regions is regulated is not known. Methods and Results:Original received September 15, 2011; revision received January 12, 2012; accepted January 18, 2012. In December 2011 Nectins and nectin-like molecules (Necls) are immunoglobulinlike cell adhesion molecules that are essential for the formation of cell-cell adhesions, and these molecules regulate a variety of cellular functions, including cell polarization, differentiation, movement, proliferation, and survival. 7,8 Necls comprise a family with 5 members, Necl-1 to -5, and among these, Necl-5 exhibits distinctive expression profiles. Necl-5 was originally identified as human poliovirus receptor (PVR), also termed CD155, 9,10 and as rodent Tage4, which is overexpressed in rodent colon carcinoma. 11,12 Necl-5 is expressed ubiquitously, but its expression level is extremely low in most adult organs in rodents. 13,14 However, it becomes upregulated in the developing or regenerating liver 15,16 and transformed cells. 17,18 In NIH3T3 cells, Necl-5 forms a complex with integrin ␣ V ␤ 3 and PDGFR, and the formation of this complex enhances cell movement and proliferation. 19 However, the function of Necl-5 and its mode of action in vascular endothelial ...

No abstract

The apical junctional complex consists of adherens junctions (AJs) and tight junctions (TJs) in polarized epithelial cells, which are attached to each other to form a sheet. Actin filaments (F-actin) are associated with AJs and TJs and required for the formation and maintenance of this complex. l-Afadin is an F-actin-binding protein, which is localized at AJs through binding to the cell adhesion molecule nectin, and regulates the formation of AJs and TJs. However, the role of the F-actin-binding activity of l-afadin for the formation of the apical junctional complex remains unknown. We generated here the cultured EpH4 mouse mammary epithelial cells in which afadin was genetically ablated. In the Ca switch assay, the formation of both AJs and TJs was markedly impaired in the afadin-deficient cells. Re-expression of l-afadin in the afadin-deficient cells fully restored the formation of both AJs and TJs, but the re-expression of the l-afadin mutant lacking the FAB domain did not completely restore the formation of AJs or TJs. These results indicate that the F-actin-binding activity of l-afadin is required for enhancing the formation of both AJs and TJs.